> "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> (TSX: NRI), a Canadian
> drug development company focused on the research and development of
> drug products delivered
> to and through the skin using its topical and transdermal drug
> delivery technologies, announced
> today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> incentive program
> designed to encourage the early exercise of 20,012,494 warrants (the
> “November 2009 Warrants”),
> 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> (the “July 2009
> Warrants”).
> To the extent that holders of the warrants take advantage of the
> opportunity, the early exercise of
> the warrants will provide Nuvo with additional capital to continue to
> execute its current business
> plan. The proceeds of the early exercise will fund capital
> requirements relating to the development
> and commercialization of Nuvo’s pharmaceutical products, primarily its
> Pennsaid® and Pennsaid
> Plus® products, and for working capital and other corporate purposes.

> The November 2009 Warrants were issued as part of a financing
> completed in November 2004 and
> can be exercised at $0.48 until November 16, 2009.

> The June 2009 Warrants were issued as part of a financing completed in
> June 2006 and can be
> exercised at $0.50 until June 20, 2009.

> The July 2009 Warrants were issued as part of a financing completed in
> July 2007 and can be
> exercised at $0.30 until July 13, 2009.

> In order to encourage the early exercise of the warrants, Nuvo is
> amending the November 2009
> Warrants, the June 2009 Warrants and the July 2009 Warrants,
> respectively, so that upon payment
> of the applicable reduced exercise price of $0.125 (which represents
> the volume weighted average
> trading price of Nuvo common shares over the last five days) and
> surrender of the holder’s warrant
> in accordance with applicable procedures, the holder will be entitled
> to receive one common share
> of Nuvo.
> Nuvo is providing the holders of November 2009 Warrants, June 2009
> Warrants and July 2009
> Warrants an exercise period commencing on January 21, 2009 and ending
> at 5:00 p.m. (Toronto
> time) on April 3, 2009 to exercise their warrants under the offer. If
> a holder does not exercise his or
> her warrants prior to April 3, 2009, the warrants will continue to be
> exercisable for common shares
> of Nuvo on the same terms as previously existed.
> Insiders will not be eligible to participate in the warrant incentive
> program.
> The gross proceeds to Nuvo if all the November 2009 Warrants are
> exchanged is $2.5 million. The
> gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> $0.5 million. The gross
> proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> million."

> I know this is old news but I am interested in what you think the
> warrants mean and how they affect the stock price.

> Thanks.

> Will this ever move ?. It's been sitting at this price for sometime.

> On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > (TSX: NRI), a Canadian
> > drug development company focused on the research and development of
> > drug products delivered
> > to and through the skin using its topical and transdermal drug
> > delivery technologies, announced
> > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > incentive program
> > designed to encourage the early exercise of 20,012,494 warrants (the
> > “November 2009 Warrants”),
> > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > (the “July 2009
> > Warrants”).
> > To the extent that holders of the warrants take advantage of the
> > opportunity, the early exercise of
> > the warrants will provide Nuvo with additional capital to continue to
> > execute its current business
> > plan. The proceeds of the early exercise will fund capital
> > requirements relating to the development
> > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > Pennsaid® and Pennsaid
> > Plus® products, and for working capital and other corporate purposes.

> > The November 2009 Warrants were issued as part of a financing
> > completed in November 2004 and
> > can be exercised at $0.48 until November 16, 2009.

> > The June 2009 Warrants were issued as part of a financing completed in
> > June 2006 and can be
> > exercised at $0.50 until June 20, 2009.

> > The July 2009 Warrants were issued as part of a financing completed in
> > July 2007 and can be
> > exercised at $0.30 until July 13, 2009.

> > In order to encourage the early exercise of the warrants, Nuvo is
> > amending the November 2009
> > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > respectively, so that upon payment
> > of the applicable reduced exercise price of $0.125 (which represents
> > the volume weighted average
> > trading price of Nuvo common shares over the last five days) and
> > surrender of the holder’s warrant
> > in accordance with applicable procedures, the holder will be entitled
> > to receive one common share
> > of Nuvo.
> > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > Warrants and July 2009
> > Warrants an exercise period commencing on January 21, 2009 and ending
> > at 5:00 p.m. (Toronto
> > time) on April 3, 2009 to exercise their warrants under the offer. If
> > a holder does not exercise his or
> > her warrants prior to April 3, 2009, the warrants will continue to be
> > exercisable for common shares
> > of Nuvo on the same terms as previously existed.
> > Insiders will not be eligible to participate in the warrant incentive
> > program.
> > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > exchanged is $2.5 million. The
> > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > $0.5 million. The gross
> > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > million."

> > I know this is old news but I am interested in what you think the
> > warrants mean and how they affect the stock price.

> > Thanks.- Hide quoted text -

> - Show quoted text -

> wait till the july warrants expire that should move the sp ..coming to
> the last 2 weeks of FDA decision

> On Jul 1, 1:17 pm, eGlobalsoft <manoj...@yahoo.com> wrote:

> > Will this ever move ?. It's been sitting at this price for sometime.

> > On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > > (TSX: NRI), a Canadian
> > > drug development company focused on the research and development of
> > > drug products delivered
> > > to and through the skin using its topical and transdermal drug
> > > delivery technologies, announced
> > > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > > incentive program
> > > designed to encourage the early exercise of 20,012,494 warrants (the
> > > “November 2009 Warrants”),
> > > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > > (the “July 2009
> > > Warrants”).
> > > To the extent that holders of the warrants take advantage of the
> > > opportunity, the early exercise of
> > > the warrants will provide Nuvo with additional capital to continue to
> > > execute its current business
> > > plan. The proceeds of the early exercise will fund capital
> > > requirements relating to the development
> > > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > > Pennsaid® and Pennsaid
> > > Plus® products, and for working capital and other corporate purposes.

> > > The November 2009 Warrants were issued as part of a financing
> > > completed in November 2004 and
> > > can be exercised at $0.48 until November 16, 2009.

> > > The June 2009 Warrants were issued as part of a financing completed in
> > > June 2006 and can be
> > > exercised at $0.50 until June 20, 2009.

> > > The July 2009 Warrants were issued as part of a financing completed in
> > > July 2007 and can be
> > > exercised at $0.30 until July 13, 2009.

> > > In order to encourage the early exercise of the warrants, Nuvo is
> > > amending the November 2009
> > > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > > respectively, so that upon payment
> > > of the applicable reduced exercise price of $0.125 (which represents
> > > the volume weighted average
> > > trading price of Nuvo common shares over the last five days) and
> > > surrender of the holder’s warrant
> > > in accordance with applicable procedures, the holder will be entitled
> > > to receive one common share
> > > of Nuvo.
> > > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > > Warrants and July 2009
> > > Warrants an exercise period commencing on January 21, 2009 and ending
> > > at 5:00 p.m. (Toronto
> > > time) on April 3, 2009 to exercise their warrants under the offer. If
> > > a holder does not exercise his or
> > > her warrants prior to April 3, 2009, the warrants will continue to be
> > > exercisable for common shares
> > > of Nuvo on the same terms as previously existed.
> > > Insiders will not be eligible to participate in the warrant incentive
> > > program.
> > > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > > exchanged is $2.5 million. The
> > > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > > $0.5 million. The gross
> > > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > > million."

> > > I know this is old news but I am interested in what you think the
> > > warrants mean and how they affect the stock price.

> > > Thanks.- Hide quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> (TSX: NRI), a Canadian
> drug development company focused on the research and development of
> drug products delivered
> to and through the skin using its topical and transdermal drug
> delivery technologies, announced
> today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> incentive program
> designed to encourage the early exercise of 20,012,494 warrants (the
> “November 2009 Warrants”),
> 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> (the “July 2009
> Warrants”).
> To the extent that holders of the warrants take advantage of the
> opportunity, the early exercise of
> the warrants will provide Nuvo with additional capital to continue to
> execute its current business
> plan. The proceeds of the early exercise will fund capital
> requirements relating to the development
> and commercialization of Nuvo’s pharmaceutical products, primarily its
> Pennsaid® and Pennsaid
> Plus® products, and for working capital and other corporate purposes.

> The November 2009 Warrants were issued as part of a financing
> completed in November 2004 and
> can be exercised at $0.48 until November 16, 2009.

> The June 2009 Warrants were issued as part of a financing completed in
> June 2006 and can be
> exercised at $0.50 until June 20, 2009.

> The July 2009 Warrants were issued as part of a financing completed in
> July 2007 and can be
> exercised at $0.30 until July 13, 2009.

> In order to encourage the early exercise of the warrants, Nuvo is
> amending the November 2009
> Warrants, the June 2009 Warrants and the July 2009 Warrants,
> respectively, so that upon payment
> of the applicable reduced exercise price of $0.125 (which represents
> the volume weighted average
> trading price of Nuvo common shares over the last five days) and
> surrender of the holder’s warrant
> in accordance with applicable procedures, the holder will be entitled
> to receive one common share
> of Nuvo.
> Nuvo is providing the holders of November 2009 Warrants, June 2009
> Warrants and July 2009
> Warrants an exercise period commencing on January 21, 2009 and ending
> at 5:00 p.m. (Toronto
> time) on April 3, 2009 to exercise their warrants under the offer. If
> a holder does not exercise his or
> her warrants prior to April 3, 2009, the warrants will continue to be
> exercisable for common shares
> of Nuvo on the same terms as previously existed.
> Insiders will not be eligible to participate in the warrant incentive
> program.
> The gross proceeds to Nuvo if all the November 2009 Warrants are
> exchanged is $2.5 million. The
> gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> $0.5 million. The gross
> proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> million."

> I know this is old news but I am interested in what you think the
> warrants mean and how they affect the stock price.

> Thanks.

> This is what is in the Q1 report:

> "In the first quarter, we launched our second Warrant Incentive
> Program to encourage the early exercise of approximately 73.9 million
> outstanding warrants. The program was successful as 42% of the
> warrants were exercised, generating net cash proceeds of $3.7
> million."

> The breakdown of those is as follows:

> As of March 31, 2009, the Company received proceeds of $2.2 million,
> net of professional fees of $0.1 million, from the exercise of 2.1
> million November 2004 Warrants, 0.7 million June 2006 Warrants and
> 16.1 million July 2007 Warrants under this program. Subsequent to the
> quarter, the Company received additional proceeds of $1.5 million from
> the exercise of 11.8 million warrants. Total proceeds received from
> the 2009 Warrant Incentive Program, net of professional fees were $3.7
> million.

> My take on what is happening now:

> The remaining July warrants are what have been holding this thing at
> the current  levels. They expire on July 13th although the majority of
> them have been excersiced over the past month or so according to my
> calculations. Some people think the price won't move above this flat-
> line we have seen as of late until the 13th.  I believe we will  start
> to see a little movement before then, albeit probably not a whole lot.
> After the 13th this thing will start to really take off IMO probably
> pushing the $1 mark just prior to the Aug 5th proposed decision date.

> Hope this helps.

> On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > (TSX: NRI), a Canadian
> > drug development company focused on the research and development of
> > drug products delivered
> > to and through the skin using its topical and transdermal drug
> > delivery technologies, announced
> > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > incentive program
> > designed to encourage the early exercise of 20,012,494 warrants (the
> > “November 2009 Warrants”),
> > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > (the “July 2009
> > Warrants”).
> > To the extent that holders of the warrants take advantage of the
> > opportunity, the early exercise of
> > the warrants will provide Nuvo with additional capital to continue to
> > execute its current business
> > plan. The proceeds of the early exercise will fund capital
> > requirements relating to the development
> > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > Pennsaid® and Pennsaid
> > Plus® products, and for working capital and other corporate purposes.

> > The November 2009 Warrants were issued as part of a financing
> > completed in November 2004 and
> > can be exercised at $0.48 until November 16, 2009.

> > The June 2009 Warrants were issued as part of a financing completed in
> > June 2006 and can be
> > exercised at $0.50 until June 20, 2009.

> > The July 2009 Warrants were issued as part of a financing completed in
> > July 2007 and can be
> > exercised at $0.30 until July 13, 2009.

> > In order to encourage the early exercise of the warrants, Nuvo is
> > amending the November 2009
> > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > respectively, so that upon payment
> > of the applicable reduced exercise price of $0.125 (which represents
> > the volume weighted average
> > trading price of Nuvo common shares over the last five days) and
> > surrender of the holder’s warrant
> > in accordance with applicable procedures, the holder will be entitled
> > to receive one common share
> > of Nuvo.
> > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > Warrants and July 2009
> > Warrants an exercise period commencing on January 21, 2009 and ending
> > at 5:00 p.m. (Toronto
> > time) on April 3, 2009 to exercise their warrants under the offer. If
> > a holder does not exercise his or
> > her warrants prior to April 3, 2009, the warrants will continue to be
> > exercisable for common shares
> > of Nuvo on the same terms as previously existed.
> > Insiders will not be eligible to participate in the warrant incentive
> > program.
> > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > exchanged is $2.5 million. The
> > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > $0.5 million. The gross
> > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > million."

> > I know this is old news but I am interested in what you think the
> > warrants mean and how they affect the stock price.

> > Thanks.- Hide quoted text -

> - Show quoted text -

> Thanks for the info, UncleKroon.

> On Jul 2, 1:42 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > This is what is in the Q1 report:

> > "In the first quarter, we launched our second Warrant Incentive
> > Program to encourage the early exercise of approximately 73.9 million
> > outstanding warrants. The program was successful as 42% of the
> > warrants were exercised, generating net cash proceeds of $3.7
> > million."

> > The breakdown of those is as follows:

> > As of March 31, 2009, the Company received proceeds of $2.2 million,
> > net of professional fees of $0.1 million, from the exercise of 2.1
> > million November 2004 Warrants, 0.7 million June 2006 Warrants and
> > 16.1 million July 2007 Warrants under this program. Subsequent to the
> > quarter, the Company received additional proceeds of $1.5 million from
> > the exercise of 11.8 million warrants. Total proceeds received from
> > the 2009 Warrant Incentive Program, net of professional fees were $3.7
> > million.

> > My take on what is happening now:

> > The remaining July warrants are what have been holding this thing at
> > the current  levels. They expire on July 13th although the majority of
> > them have been excersiced over the past month or so according to my
> > calculations. Some people think the price won't move above this flat-
> > line we have seen as of late until the 13th.  I believe we will  start
> > to see a little movement before then, albeit probably not a whole lot.
> > After the 13th this thing will start to really take off IMO probably
> > pushing the $1 mark just prior to the Aug 5th proposed decision date.

> > Hope this helps.

> > On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > > (TSX: NRI), a Canadian
> > > drug development company focused on the research and development of
> > > drug products delivered
> > > to and through the skin using its topical and transdermal drug
> > > delivery technologies, announced
> > > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > > incentive program
> > > designed to encourage the early exercise of 20,012,494 warrants (the
> > > “November 2009 Warrants”),
> > > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > > (the “July 2009
> > > Warrants”).
> > > To the extent that holders of the warrants take advantage of the
> > > opportunity, the early exercise of
> > > the warrants will provide Nuvo with additional capital to continue to
> > > execute its current business
> > > plan. The proceeds of the early exercise will fund capital
> > > requirements relating to the development
> > > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > > Pennsaid® and Pennsaid
> > > Plus® products, and for working capital and other corporate purposes.

> > > The November 2009 Warrants were issued as part of a financing
> > > completed in November 2004 and
> > > can be exercised at $0.48 until November 16, 2009.

> > > The June 2009 Warrants were issued as part of a financing completed in
> > > June 2006 and can be
> > > exercised at $0.50 until June 20, 2009.

> > > The July 2009 Warrants were issued as part of a financing completed in
> > > July 2007 and can be
> > > exercised at $0.30 until July 13, 2009.

> > > In order to encourage the early exercise of the warrants, Nuvo is
> > > amending the November 2009
> > > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > > respectively, so that upon payment
> > > of the applicable reduced exercise price of $0.125 (which represents
> > > the volume weighted average
> > > trading price of Nuvo common shares over the last five days) and
> > > surrender of the holder’s warrant
> > > in accordance with applicable procedures, the holder will be entitled
> > > to receive one common share
> > > of Nuvo.
> > > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > > Warrants and July 2009
> > > Warrants an exercise period commencing on January 21, 2009 and ending
> > > at 5:00 p.m. (Toronto
> > > time) on April 3, 2009 to exercise their warrants under the offer. If
> > > a holder does not exercise his or
> > > her warrants prior to April 3, 2009, the warrants will continue to be
> > > exercisable for common shares
> > > of Nuvo on the same terms as previously existed.
> > > Insiders will not be eligible to participate in the warrant incentive
> > > program.
> > > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > > exchanged is $2.5 million. The
> > > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > > $0.5 million. The gross
> > > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > > million."

> > > I know this is old news but I am interested in what you think the
> > > warrants mean and how they affect the stock price.

> > > Thanks.- Hide quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> Well for me I have been buying every dip i get. An dnt get this stock
> wrong there have been a lot of speculation around it. Contracts here
> and there. Commerce aliance over there and all that. My best estimate
> is that will see $0.75 b4 FDA approve week. i told my buddy this
> consolidation sequence we had on BIEL and i bght the dip dwn when it
> came a liltle lower than the $0.008 its been pulling for a while and
> after good news it took off over 400% and u bet its still climbing
> mostly for its numerous programes yet to be concluded. NRI i hope will
> amrk the completion of my trading success this year. But every
> investment comes with its own level or risk. My advise do the risk
> reward matrix of your trading style and make the choice. good luck
> guys. And thanks unclekroon.

> regards.

> On Jul 2, 12:59 pm, "Paula&Max million" <1million2...@gmail.com>
> wrote:

> > Thanks for the info, UncleKroon.

> > On Jul 2, 1:42 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > > This is what is in the Q1 report:

> > > "In the first quarter, we launched our second Warrant Incentive
> > > Program to encourage the early exercise of approximately 73.9 million
> > > outstanding warrants. The program was successful as 42% of the
> > > warrants were exercised, generating net cash proceeds of $3.7
> > > million."

> > > The breakdown of those is as follows:

> > > As of March 31, 2009, the Company received proceeds of $2.2 million,
> > > net of professional fees of $0.1 million, from the exercise of 2.1
> > > million November 2004 Warrants, 0.7 million June 2006 Warrants and
> > > 16.1 million July 2007 Warrants under this program. Subsequent to the
> > > quarter, the Company received additional proceeds of $1.5 million from
> > > the exercise of 11.8 million warrants. Total proceeds received from
> > > the 2009 Warrant Incentive Program, net of professional fees were $3.7
> > > million.

> > > My take on what is happening now:

> > > The remaining July warrants are what have been holding this thing at
> > > the current  levels. They expire on July 13th although the majority of
> > > them have been excersiced over the past month or so according to my
> > > calculations. Some people think the price won't move above this flat-
> > > line we have seen as of late until the 13th.  I believe we will  start
> > > to see a little movement before then, albeit probably not a whole lot.
> > > After the 13th this thing will start to really take off IMO probably
> > > pushing the $1 mark just prior to the Aug 5th proposed decision date.

> > > Hope this helps.

> > > On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > > > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > > > (TSX: NRI), a Canadian
> > > > drug development company focused on the research and development of
> > > > drug products delivered
> > > > to and through the skin using its topical and transdermal drug
> > > > delivery technologies, announced
> > > > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > > > incentive program
> > > > designed to encourage the early exercise of 20,012,494 warrants (the
> > > > “November 2009 Warrants”),
> > > > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > > > (the “July 2009
> > > > Warrants”).
> > > > To the extent that holders of the warrants take advantage of the
> > > > opportunity, the early exercise of
> > > > the warrants will provide Nuvo with additional capital to continue to
> > > > execute its current business
> > > > plan. The proceeds of the early exercise will fund capital
> > > > requirements relating to the development
> > > > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > > > Pennsaid® and Pennsaid
> > > > Plus® products, and for working capital and other corporate purposes.

> > > > The November 2009 Warrants were issued as part of a financing
> > > > completed in November 2004 and
> > > > can be exercised at $0.48 until November 16, 2009.

> > > > The June 2009 Warrants were issued as part of a financing completed in
> > > > June 2006 and can be
> > > > exercised at $0.50 until June 20, 2009.

> > > > The July 2009 Warrants were issued as part of a financing completed in
> > > > July 2007 and can be
> > > > exercised at $0.30 until July 13, 2009.

> > > > In order to encourage the early exercise of the warrants, Nuvo is
> > > > amending the November 2009
> > > > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > > > respectively, so that upon payment
> > > > of the applicable reduced exercise price of $0.125 (which represents
> > > > the volume weighted average
> > > > trading price of Nuvo common shares over the last five days) and
> > > > surrender of the holder’s warrant
> > > > in accordance with applicable procedures, the holder will be entitled
> > > > to receive one common share
> > > > of Nuvo.
> > > > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > > > Warrants and July 2009
> > > > Warrants an exercise period commencing on January 21, 2009 and ending
> > > > at 5:00 p.m. (Toronto
> > > > time) on April 3, 2009 to exercise their warrants under the offer. If
> > > > a holder does not exercise his or
> > > > her warrants prior to April 3, 2009, the warrants will continue to be
> > > > exercisable for common shares
> > > > of Nuvo on the same terms as previously existed.
> > > > Insiders will not be eligible to participate in the warrant incentive
> > > > program.
> > > > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > > > exchanged is $2.5 million. The
> > > > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > > > $0.5 million. The gross
> > > > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > > > million."

> > > > I know this is old news but I am interested in what you think the
> > > > warrants mean and how they affect the stock price.

> > > > Thanks.- Hide quoted text -

> > > - Show quoted text -- Hide quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> (TSX: NRI), a Canadian
> drug development company focused on the research and development of
> drug products delivered
> to and through the skin using its topical and transdermal drug
> delivery technologies, announced
> today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> incentive program
> designed to encourage the early exercise of 20,012,494 warrants (the
> “November 2009 Warrants”),
> 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> (the “July 2009
> Warrants”).
> To the extent that holders of the warrants take advantage of the
> opportunity, the early exercise of
> the warrants will provide Nuvo with additional capital to continue to
> execute its current business
> plan. The proceeds of the early exercise will fund capital
> requirements relating to the development
> and commercialization of Nuvo’s pharmaceutical products, primarily its
> Pennsaid® and Pennsaid
> Plus® products, and for working capital and other corporate purposes.

> The November 2009 Warrants were issued as part of a financing
> completed in November 2004 and
> can be exercised at $0.48 until November 16, 2009.

> The June 2009 Warrants were issued as part of a financing completed in
> June 2006 and can be
> exercised at $0.50 until June 20, 2009.

> The July 2009 Warrants were issued as part of a financing completed in
> July 2007 and can be
> exercised at $0.30 until July 13, 2009.

> In order to encourage the early exercise of the warrants, Nuvo is
> amending the November 2009
> Warrants, the June 2009 Warrants and the July 2009 Warrants,
> respectively, so that upon payment
> of the applicable reduced exercise price of $0.125 (which represents
> the volume weighted average
> trading price of Nuvo common shares over the last five days) and
> surrender of the holder’s warrant
> in accordance with applicable procedures, the holder will be entitled
> to receive one common share
> of Nuvo.
> Nuvo is providing the holders of November 2009 Warrants, June 2009
> Warrants and July 2009
> Warrants an exercise period commencing on January 21, 2009 and ending
> at 5:00 p.m. (Toronto
> time) on April 3, 2009 to exercise their warrants under the offer. If
> a holder does not exercise his or
> her warrants prior to April 3, 2009, the warrants will continue to be
> exercisable for common shares
> of Nuvo on the same terms as previously existed.
> Insiders will not be eligible to participate in the warrant incentive
> program.
> The gross proceeds to Nuvo if all the November 2009 Warrants are
> exchanged is $2.5 million. The
> gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> $0.5 million. The gross
> proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> million."

> I know this is old news but I am interested in what you think the
> warrants mean and how they affect the stock price.

> Thanks.

> 9th most active stock on the TSX this morning - lots of interest, it
> wants to fly up.  Can't wait till these warrants expire.

> On Jul 3, 6:25 am, henrychimex <henrychim...@googlemail.com> wrote:

> > Well for me I have been buying every dip i get. An dnt get this stock
> > wrong there have been a lot of speculation around it. Contracts here
> > and there. Commerce aliance over there and all that. My best estimate
> > is that will see $0.75 b4 FDA approve week. i told my buddy this
> > consolidation sequence we had on BIEL and i bght the dip dwn when it
> > came a liltle lower than the $0.008 its been pulling for a while and
> > after good news it took off over 400% and u bet its still climbing
> > mostly for its numerous programes yet to be concluded. NRI i hope will
> > amrk the completion of my trading success this year. But every
> > investment comes with its own level or risk. My advise do the risk
> > reward matrix of your trading style and make the choice. good luck
> > guys. And thanks unclekroon.

> > regards.

> > On Jul 2, 12:59 pm, "Paula&Max million" <1million2...@gmail.com>
> > wrote:

> > > Thanks for the info, UncleKroon.

> > > On Jul 2, 1:42 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > > > This is what is in the Q1 report:

> > > > "In the first quarter, we launched our second Warrant Incentive
> > > > Program to encourage the early exercise of approximately 73.9 million
> > > > outstanding warrants. The program was successful as 42% of the
> > > > warrants were exercised, generating net cash proceeds of $3.7
> > > > million."

> > > > The breakdown of those is as follows:

> > > > As of March 31, 2009, the Company received proceeds of $2.2 million,
> > > > net of professional fees of $0.1 million, from the exercise of 2.1
> > > > million November 2004 Warrants, 0.7 million June 2006 Warrants and
> > > > 16.1 million July 2007 Warrants under this program. Subsequent to the
> > > > quarter, the Company received additional proceeds of $1.5 million from
> > > > the exercise of 11.8 million warrants. Total proceeds received from
> > > > the 2009 Warrant Incentive Program, net of professional fees were $3.7
> > > > million.

> > > > My take on what is happening now:

> > > > The remaining July warrants are what have been holding this thing at
> > > > the current  levels. They expire on July 13th although the majority of
> > > > them have been excersiced over the past month or so according to my
> > > > calculations. Some people think the price won't move above this flat-
> > > > line we have seen as of late until the 13th.  I believe we will  start
> > > > to see a little movement before then, albeit probably not a whole lot.
> > > > After the 13th this thing will start to really take off IMO probably
> > > > pushing the $1 mark just prior to the Aug 5th proposed decision date.

> > > > Hope this helps.

> > > > On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > > > > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > > > > (TSX: NRI), a Canadian
> > > > > drug development company focused on the research and development of
> > > > > drug products delivered
> > > > > to and through the skin using its topical and transdermal drug
> > > > > delivery technologies, announced
> > > > > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > > > > incentive program
> > > > > designed to encourage the early exercise of 20,012,494 warrants (the
> > > > > “November 2009 Warrants”),
> > > > > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > > > > (the “July 2009
> > > > > Warrants”).
> > > > > To the extent that holders of the warrants take advantage of the
> > > > > opportunity, the early exercise of
> > > > > the warrants will provide Nuvo with additional capital to continue to
> > > > > execute its current business
> > > > > plan. The proceeds of the early exercise will fund capital
> > > > > requirements relating to the development
> > > > > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > > > > Pennsaid® and Pennsaid
> > > > > Plus® products, and for working capital and other corporate purposes.

> > > > > The November 2009 Warrants were issued as part of a financing
> > > > > completed in November 2004 and
> > > > > can be exercised at $0.48 until November 16, 2009.

> > > > > The June 2009 Warrants were issued as part of a financing completed in
> > > > > June 2006 and can be
> > > > > exercised at $0.50 until June 20, 2009.

> > > > > The July 2009 Warrants were issued as part of a financing completed in
> > > > > July 2007 and can be
> > > > > exercised at $0.30 until July 13, 2009.

> > > > > In order to encourage the early exercise of the warrants, Nuvo is
> > > > > amending the November 2009
> > > > > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > > > > respectively, so that upon payment
> > > > > of the applicable reduced exercise price of $0.125 (which represents
> > > > > the volume weighted average
> > > > > trading price of Nuvo common shares over the last five days) and
> > > > > surrender of the holder’s warrant
> > > > > in accordance with applicable procedures, the holder will be entitled
> > > > > to receive one common share
> > > > > of Nuvo.
> > > > > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > > > > Warrants and July 2009
> > > > > Warrants an exercise period commencing on January 21, 2009 and ending
> > > > > at 5:00 p.m. (Toronto
> > > > > time) on April 3, 2009 to exercise their warrants under the offer. If
> > > > > a holder does not exercise his or
> > > > > her warrants prior to April 3, 2009, the warrants will continue to be
> > > > > exercisable for common shares
> > > > > of Nuvo on the same terms as previously existed.
> > > > > Insiders will not be eligible to participate in the warrant incentive
> > > > > program.
> > > > > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > > > > exchanged is $2.5 million. The
> > > > > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > > > > $0.5 million. The gross
> > > > > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > > > > million."

> > > > > I know this is old news but I am interested in what you think the
> > > > > warrants mean and how they affect the stock price.

> > > > > Thanks.- Hide quoted text -

> > > > - Show quoted text -- Hide quoted text -

> > > - Show quoted text -- Hide quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> Looks like she might want to go!!

> On Jul 3, 10:31 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > 9th most active stock on the TSX this morning - lots of interest, it
> > wants to fly up.  Can't wait till these warrants expire.

> > On Jul 3, 6:25 am, henrychimex <henrychim...@googlemail.com> wrote:

> > > Well for me I have been buying every dip i get. An dnt get this stock
> > > wrong there have been a lot of speculation around it. Contracts here
> > > and there. Commerce aliance over there and all that. My best estimate
> > > is that will see $0.75 b4 FDA approve week. i told my buddy this
> > > consolidation sequence we had on BIEL and i bght the dip dwn when it
> > > came a liltle lower than the $0.008 its been pulling for a while and
> > > after good news it took off over 400% and u bet its still climbing
> > > mostly for its numerous programes yet to be concluded. NRI i hope will
> > > amrk the completion of my trading success this year. But every
> > > investment comes with its own level or risk. My advise do the risk
> > > reward matrix of your trading style and make the choice. good luck
> > > guys. And thanks unclekroon.

> > > regards.

> > > On Jul 2, 12:59 pm, "Paula&Max million" <1million2...@gmail.com>
> > > wrote:

> > > > Thanks for the info, UncleKroon.

> > > > On Jul 2, 1:42 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > > > > This is what is in the Q1 report:

> > > > > "In the first quarter, we launched our second Warrant Incentive
> > > > > Program to encourage the early exercise of approximately 73.9 million
> > > > > outstanding warrants. The program was successful as 42% of the
> > > > > warrants were exercised, generating net cash proceeds of $3.7
> > > > > million."

> > > > > The breakdown of those is as follows:

> > > > > As of March 31, 2009, the Company received proceeds of $2.2 million,
> > > > > net of professional fees of $0.1 million, from the exercise of 2.1
> > > > > million November 2004 Warrants, 0.7 million June 2006 Warrants and
> > > > > 16.1 million July 2007 Warrants under this program. Subsequent to the
> > > > > quarter, the Company received additional proceeds of $1.5 million from
> > > > > the exercise of 11.8 million warrants. Total proceeds received from
> > > > > the 2009 Warrant Incentive Program, net of professional fees were $3.7
> > > > > million.

> > > > > My take on what is happening now:

> > > > > The remaining July warrants are what have been holding this thing at
> > > > > the current  levels. They expire on July 13th although the majority of
> > > > > them have been excersiced over the past month or so according to my
> > > > > calculations. Some people think the price won't move above this flat-
> > > > > line we have seen as of late until the 13th.  I believe we will  start
> > > > > to see a little movement before then, albeit probably not a whole lot.
> > > > > After the 13th this thing will start to really take off IMO probably
> > > > > pushing the $1 mark just prior to the Aug 5th proposed decision date.

> > > > > Hope this helps.

> > > > > On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > > > > > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > > > > > (TSX: NRI), a Canadian
> > > > > > drug development company focused on the research and development of
> > > > > > drug products delivered
> > > > > > to and through the skin using its topical and transdermal drug
> > > > > > delivery technologies, announced
> > > > > > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > > > > > incentive program
> > > > > > designed to encourage the early exercise of 20,012,494 warrants (the
> > > > > > “November 2009 Warrants”),
> > > > > > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > > > > > (the “July 2009
> > > > > > Warrants”).
> > > > > > To the extent that holders of the warrants take advantage of the
> > > > > > opportunity, the early exercise of
> > > > > > the warrants will provide Nuvo with additional capital to continue to
> > > > > > execute its current business
> > > > > > plan. The proceeds of the early exercise will fund capital
> > > > > > requirements relating to the development
> > > > > > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > > > > > Pennsaid® and Pennsaid
> > > > > > Plus® products, and for working capital and other corporate purposes.

> > > > > > The November 2009 Warrants were issued as part of a financing
> > > > > > completed in November 2004 and
> > > > > > can be exercised at $0.48 until November 16, 2009.

> > > > > > The June 2009 Warrants were issued as part of a financing completed in
> > > > > > June 2006 and can be
> > > > > > exercised at $0.50 until June 20, 2009.

> > > > > > The July 2009 Warrants were issued as part of a financing completed in
> > > > > > July 2007 and can be
> > > > > > exercised at $0.30 until July 13, 2009.

> > > > > > In order to encourage the early exercise of the warrants, Nuvo is
> > > > > > amending the November 2009
> > > > > > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > > > > > respectively, so that upon payment
> > > > > > of the applicable reduced exercise price of $0.125 (which represents
> > > > > > the volume weighted average
> > > > > > trading price of Nuvo common shares over the last five days) and
> > > > > > surrender of the holder’s warrant
> > > > > > in accordance with applicable procedures, the holder will be entitled
> > > > > > to receive one common share
> > > > > > of Nuvo.
> > > > > > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > > > > > Warrants and July 2009
> > > > > > Warrants an exercise period commencing on January 21, 2009 and ending
> > > > > > at 5:00 p.m. (Toronto
> > > > > > time) on April 3, 2009 to exercise their warrants under the offer. If
> > > > > > a holder does not exercise his or
> > > > > > her warrants prior to April 3, 2009, the warrants will continue to be
> > > > > > exercisable for common shares
> > > > > > of Nuvo on the same terms as previously existed.
> > > > > > Insiders will not be eligible to participate in the warrant incentive
> > > > > > program.
> > > > > > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > > > > > exchanged is $2.5 million. The
> > > > > > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > > > > > $0.5 million. The gross
> > > > > > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > > > > > million."

> > > > > > I know this is old news but I am interested in what you think the
> > > > > > warrants mean and how they affect the stock price.

> > > > > > Thanks.- Hide quoted text -

> > > > > - Show quoted text -- Hide quoted text -

> > > > - Show quoted text -- Hide quoted text -

> > > - Show quoted text -- Hide quoted text -

> > - Show quoted text -

> something seems fishy about the increase

> On Jul 3, 1:17 pm, UncleKroon <dawei...@yahoo.ca> wrote:

> > Looks like she might want to go!!

> > On Jul 3, 10:31 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > > 9th most active stock on the TSX this morning - lots of interest, it
> > > wants to fly up.  Can't wait till these warrants expire.

> > > On Jul 3, 6:25 am, henrychimex <henrychim...@googlemail.com> wrote:

> > > > Well for me I have been buying every dip i get. An dnt get this stock
> > > > wrong there have been a lot of speculation around it. Contracts here
> > > > and there. Commerce aliance over there and all that. My best estimate
> > > > is that will see $0.75 b4 FDA approve week. i told my buddy this
> > > > consolidation sequence we had on BIEL and i bght the dip dwn when it
> > > > came a liltle lower than the $0.008 its been pulling for a while and
> > > > after good news it took off over 400% and u bet its still climbing
> > > > mostly for its numerous programes yet to be concluded. NRI i hope will
> > > > amrk the completion of my trading success this year. But every
> > > > investment comes with its own level or risk. My advise do the risk
> > > > reward matrix of your trading style and make the choice. good luck
> > > > guys. And thanks unclekroon.

> > > > regards.

> > > > On Jul 2, 12:59 pm, "Paula&Max million" <1million2...@gmail.com>
> > > > wrote:

> > > > > Thanks for the info, UncleKroon.

> > > > > On Jul 2, 1:42 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > > > > > This is what is in the Q1 report:

> > > > > > "In the first quarter, we launched our second Warrant Incentive
> > > > > > Program to encourage the early exercise of approximately 73.9 million
> > > > > > outstanding warrants. The program was successful as 42% of the
> > > > > > warrants were exercised, generating net cash proceeds of $3.7
> > > > > > million."

> > > > > > The breakdown of those is as follows:

> > > > > > As of March 31, 2009, the Company received proceeds of $2.2 million,
> > > > > > net of professional fees of $0.1 million, from the exercise of 2.1
> > > > > > million November 2004 Warrants, 0.7 million June 2006 Warrants and
> > > > > > 16.1 million July 2007 Warrants under this program. Subsequent to the
> > > > > > quarter, the Company received additional proceeds of $1.5 million from
> > > > > > the exercise of 11.8 million warrants. Total proceeds received from
> > > > > > the 2009 Warrant Incentive Program, net of professional fees were $3.7
> > > > > > million.

> > > > > > My take on what is happening now:

> > > > > > The remaining July warrants are what have been holding this thing at
> > > > > > the current  levels. They expire on July 13th although the majority of
> > > > > > them have been excersiced over the past month or so according to my
> > > > > > calculations. Some people think the price won't move above this flat-
> > > > > > line we have seen as of late until the 13th.  I believe we will  start
> > > > > > to see a little movement before then, albeit probably not a whole lot.
> > > > > > After the 13th this thing will start to really take off IMO probably
> > > > > > pushing the $1 mark just prior to the Aug 5th proposed decision date.

> > > > > > Hope this helps.

> > > > > > On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > > > > > > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > > > > > > (TSX: NRI), a Canadian
> > > > > > > drug development company focused on the research and development of
> > > > > > > drug products delivered
> > > > > > > to and through the skin using its topical and transdermal drug
> > > > > > > delivery technologies, announced
> > > > > > > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > > > > > > incentive program
> > > > > > > designed to encourage the early exercise of 20,012,494 warrants (the
> > > > > > > “November 2009 Warrants”),
> > > > > > > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > > > > > > (the “July 2009
> > > > > > > Warrants”).
> > > > > > > To the extent that holders of the warrants take advantage of the
> > > > > > > opportunity, the early exercise of
> > > > > > > the warrants will provide Nuvo with additional capital to continue to
> > > > > > > execute its current business
> > > > > > > plan. The proceeds of the early exercise will fund capital
> > > > > > > requirements relating to the development
> > > > > > > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > > > > > > Pennsaid® and Pennsaid
> > > > > > > Plus® products, and for working capital and other corporate purposes.

> > > > > > > The November 2009 Warrants were issued as part of a financing
> > > > > > > completed in November 2004 and
> > > > > > > can be exercised at $0.48 until November 16, 2009.

> > > > > > > The June 2009 Warrants were issued as part of a financing completed in
> > > > > > > June 2006 and can be
> > > > > > > exercised at $0.50 until June 20, 2009.

> > > > > > > The July 2009 Warrants were issued as part of a financing completed in
> > > > > > > July 2007 and can be
> > > > > > > exercised at $0.30 until July 13, 2009.

> > > > > > > In order to encourage the early exercise of the warrants, Nuvo is
> > > > > > > amending the November 2009
> > > > > > > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > > > > > > respectively, so that upon payment
> > > > > > > of the applicable reduced exercise price of $0.125 (which represents
> > > > > > > the volume weighted average
> > > > > > > trading price of Nuvo common shares over the last five days) and
> > > > > > > surrender of the holder’s warrant
> > > > > > > in accordance with applicable procedures, the holder will be entitled
> > > > > > > to receive one common share
> > > > > > > of Nuvo.
> > > > > > > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > > > > > > Warrants and July 2009
> > > > > > > Warrants an exercise period commencing on January 21, 2009 and ending
> > > > > > > at 5:00 p.m. (Toronto
> > > > > > > time) on April 3, 2009 to exercise their warrants under the offer. If
> > > > > > > a holder does not exercise his or
> > > > > > > her warrants prior to April 3, 2009, the warrants will continue to be
> > > > > > > exercisable for common shares
> > > > > > > of Nuvo on the same terms as previously existed.
> > > > > > > Insiders will not be eligible to participate in the warrant incentive
> > > > > > > program.
> > > > > > > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > > > > > > exchanged is $2.5 million. The
> > > > > > > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > > > > > > $0.5 million. The gross
> > > > > > > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > > > > > > million."

> > > > > > > I know this is old news but I am interested in what you think the
> > > > > > > warrants mean and how they affect the stock price.

> > > > > > > Thanks.- Hide quoted text -

> > > > > > - Show quoted text -- Hide quoted text -

> > > > > - Show quoted text -- Hide quoted text -

> > > > - Show quoted text -- Hide quoted text -

> > > - Show quoted text -

> what do you guys suggest as closing sp on tuesday??

> On Jul 3, 11:26 am, Jesse <jesse.bad...@gmail.com> wrote:

> > something seems fishy about the increase

> > On Jul 3, 1:17 pm, UncleKroon <dawei...@yahoo.ca> wrote:

> > > Looks like she might want to go!!

> > > On Jul 3, 10:31 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > > > 9th most active stock on the TSX this morning - lots of interest, it
> > > > wants to fly up.  Can't wait till these warrants expire.

> > > > On Jul 3, 6:25 am, henrychimex <henrychim...@googlemail.com> wrote:

> > > > > Well for me I have been buying every dip i get. An dnt get this stock
> > > > > wrong there have been a lot of speculation around it. Contracts here
> > > > > and there. Commerce aliance over there and all that. My best estimate
> > > > > is that will see $0.75 b4 FDA approve week. i told my buddy this
> > > > > consolidation sequence we had on BIEL and i bght the dip dwn when it
> > > > > came a liltle lower than the $0.008 its been pulling for a while and
> > > > > after good news it took off over 400% and u bet its still climbing
> > > > > mostly for its numerous programes yet to be concluded. NRI i hope will
> > > > > amrk the completion of my trading success this year. But every
> > > > > investment comes with its own level or risk. My advise do the risk
> > > > > reward matrix of your trading style and make the choice. good luck
> > > > > guys. And thanks unclekroon.

> > > > > regards.

> > > > > On Jul 2, 12:59 pm, "Paula&Max million" <1million2...@gmail.com>
> > > > > wrote:

> > > > > > Thanks for the info, UncleKroon.

> > > > > > On Jul 2, 1:42 am, UncleKroon <dawei...@yahoo.ca> wrote:

> > > > > > > This is what is in the Q1 report:

> > > > > > > "In the first quarter, we launched our second Warrant Incentive
> > > > > > > Program to encourage the early exercise of approximately 73.9 million
> > > > > > > outstanding warrants. The program was successful as 42% of the
> > > > > > > warrants were exercised, generating net cash proceeds of $3.7
> > > > > > > million."

> > > > > > > The breakdown of those is as follows:

> > > > > > > As of March 31, 2009, the Company received proceeds of $2.2 million,
> > > > > > > net of professional fees of $0.1 million, from the exercise of 2.1
> > > > > > > million November 2004 Warrants, 0.7 million June 2006 Warrants and
> > > > > > > 16.1 million July 2007 Warrants under this program. Subsequent to the
> > > > > > > quarter, the Company received additional proceeds of $1.5 million from
> > > > > > > the exercise of 11.8 million warrants. Total proceeds received from
> > > > > > > the 2009 Warrant Incentive Program, net of professional fees were $3.7
> > > > > > > million.

> > > > > > > My take on what is happening now:

> > > > > > > The remaining July warrants are what have been holding this thing at
> > > > > > > the current  levels. They expire on July 13th although the majority of
> > > > > > > them have been excersiced over the past month or so according to my
> > > > > > > calculations. Some people think the price won't move above this flat-
> > > > > > > line we have seen as of late until the 13th.  I believe we will  start
> > > > > > > to see a little movement before then, albeit probably not a whole lot.
> > > > > > > After the 13th this thing will start to really take off IMO probably
> > > > > > > pushing the $1 mark just prior to the Aug 5th proposed decision date.

> > > > > > > Hope this helps.

> > > > > > > On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > > > > > > > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > > > > > > > (TSX: NRI), a Canadian
> > > > > > > > drug development company focused on the research and development of
> > > > > > > > drug products delivered
> > > > > > > > to and through the skin using its topical and transdermal drug
> > > > > > > > delivery technologies, announced
> > > > > > > > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > > > > > > > incentive program
> > > > > > > > designed to encourage the early exercise of 20,012,494 warrants (the
> > > > > > > > “November 2009 Warrants”),
> > > > > > > > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > > > > > > > (the “July 2009
> > > > > > > > Warrants”).
> > > > > > > > To the extent that holders of the warrants take advantage of the
> > > > > > > > opportunity, the early exercise of
> > > > > > > > the warrants will provide Nuvo with additional capital to continue to
> > > > > > > > execute its current business
> > > > > > > > plan. The proceeds of the early exercise will fund capital
> > > > > > > > requirements relating to the development
> > > > > > > > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > > > > > > > Pennsaid® and Pennsaid
> > > > > > > > Plus® products, and for working capital and other corporate purposes.

> > > > > > > > The November 2009 Warrants were issued as part of a financing
> > > > > > > > completed in November 2004 and
> > > > > > > > can be exercised at $0.48 until November 16, 2009.

> > > > > > > > The June 2009 Warrants were issued as part of a financing completed in
> > > > > > > > June 2006 and can be
> > > > > > > > exercised at $0.50 until June 20, 2009.

> > > > > > > > The July 2009 Warrants were issued as part of a financing completed in
> > > > > > > > July 2007 and can be
> > > > > > > > exercised at $0.30 until July 13, 2009.

> > > > > > > > In order to encourage the early exercise of the warrants, Nuvo is
> > > > > > > > amending the November 2009
> > > > > > > > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > > > > > > > respectively, so that upon payment
> > > > > > > > of the applicable reduced exercise price of $0.125 (which represents
> > > > > > > > the volume weighted average
> > > > > > > > trading price of Nuvo common shares over the last five days) and
> > > > > > > > surrender of the holder’s warrant
> > > > > > > > in accordance with applicable procedures, the holder will be entitled
> > > > > > > > to receive one common share
> > > > > > > > of Nuvo.
> > > > > > > > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > > > > > > > Warrants and July 2009
> > > > > > > > Warrants an exercise period commencing on January 21, 2009 and ending
> > > > > > > > at 5:00 p.m. (Toronto
> > > > > > > > time) on April 3, 2009 to exercise their warrants under the offer. If
> > > > > > > > a holder does not exercise his or
> > > > > > > > her warrants prior to April 3, 2009, the warrants will continue to be
> > > > > > > > exercisable for common shares
> > > > > > > > of Nuvo on the same terms as previously existed.
> > > > > > > > Insiders will not be eligible to participate in the warrant incentive
> > > > > > > > program.
> > > > > > > > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > > > > > > > exchanged is $2.5 million. The
> > > > > > > > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > > > > > > > $0.5 million. The gross
> > > > > > > > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > > > > > > > million."

> > > > > > > > I know this is old news but I am interested in what you think the
> > > > > > > > warrants mean and how they affect the stock price.

> > > > > > > > Thanks.- Hide quoted text -

> > > > > > > - Show quoted text -- Hide quoted text -

> > > > > > - Show quoted text -- Hide quoted text -

> > > > > - Show quoted text -- Hide quoted text -

> > > > - Show quoted text -- Hide quoted text -

> - Show quoted text -